Dr. Matthew Katz, pancreatic cancer expert surgeon at the MD Anderson Cancer Center in Houston, TX, finished his comprehensive webinar presentation on management of potentially resectable pancreatic cancer with a discussion of the need for systemic therapy (in this setting, chemotherapy) alongside “local” treatments that focus on the location of the primary cancer, such as surgery and/or radiation. Chemotherapy is considered a beneficial component in the management of nearly all cases of pancreatic cancer, even when the scans and eyes of the surgeon indicate there is no evidence of the cancer outside of the area resected.
In this last podcast from his talk, Dr. Katz summarizes the standard approach of surgery followed by chemo or chemo/radiation, or the alternative they tend to favor at MD Anderson of the systemic therapy being delivered prior to planned surgery afterward. Here are the video and audio versions of the podcast along with the transcript and figures.
The fourth part of Dr. Katz’s presentation covered what the surgery for pancreatic cancer entails, the most common complications from this challenging operation, and the critical importance of the experience of the surgical team. Especially for complex procedures like the “pancreaticoduodenectomy”, or Whipple resection, which is the required curative surgery surgery for pancreatic cancer, the experience of the medical team is remarkably important and correlated with the probability of long-term success.
Here’s the video and audio versions of the podcast, along with the transcript and figures for the program:
The third part of surgical oncologist and pancreatic cancer surgeon Matthew Katz’s presentation on pancreatic cancer covered how it is determined whether a patient is a good candidate for the rigorous surgery required for localized pancreatic cancer. This encompasses two important questions: is there a realistic potential to resected all of the cancer, and can a patient safely tolerate the surgery without the surgery causing prohibitive damage, either because of the cancer invading into critical structures or the challenge of the surgery itself? This is always a challenging decision and challenging surgery, and Dr. Katz discusses that important process.
Here are the video and audio versions of the podcast, along with the transcript and figures for them.
As is the case for just about all cancers, the staging of pancreatic cancer is a critical question that has significant implications for its management options and prognosis. In this portion of the webinar by Dr. Matthew Katz, surgical oncologist with a particular specialty in pancreatic cancer, discusses the process of clarifying the stage of pancreatic cancer, in anticipation of the next step of determining the recommended treatment approach.
Here are the video and audio versions of the podcast, along with the transcript and figures for this program.